Andrien, Jr.; Bruce A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Andrien, Jr.; Bruce A..The latest application filed is for "anti-c5 antibodies having improved pharmacokinetics".

Company Profile

4.20.8

Andrien, Jr.; Bruce A. - Guilford CT
Andrien, Jr.; Bruce A. - Branford CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-C5 antibodies having improved pharmacokinetics Grant 11,434,280 - Andrien, Jr. , et al. September 6, 2	2022-09-06
Anti-c5 Antibodies Having Improved Pharmacokinetics App 20200157200 - ANDRIEN, Jr.; Bruce A. ; et al.	2020-05-21
Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria with anti-C5 antibodies Grant 10,584,164 - Andrien, Jr. , et al.	2020-03-10
Anti-c5 Antibodies Having Improved Pharmacokinetics App 20190263897 - Andrien, JR.; Bruce A. ; et al.	2019-08-29
Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies Grant 10,227,400 - Andrien, Jr. , et al.	2019-03-12
Anti-c5 Antibodies Having Improved Pharmacokinetics App 20180009885 - ANDRIEN, JR.; Bruce A. ; et al.	2018-01-11
Anti-C5 antibodies having improved pharmacokinetics Grant 9,803,007 - Andrien, Jr. , et al. October 31, 2	2017-10-31
Anti-c5 Antibodies Having Improved Pharmacokinetics App 20170298123 - ANDRIEN, JR.; Bruce A. ; et al.	2017-10-19
Anti-C5 antibodies having improved pharmacokinetics Grant 9,663,574 - Andrien, Jr. , et al. May 30, 2	2017-05-30
Anti-c5 Antibodies Having Improved Pharmacokinetics App 20160251433 - ANDRIEN, JR.; Bruce A. ; et al.	2016-09-01
Anti-C5 antibodies having improved pharmacokinetics Grant 9,371,377 - Andrien, Jr. , et al. June 21, 2	2016-06-21
Anti-c5 Antibodies Having Improved Pharmacokinetics App 20160108115 - ANDRIEN, JR.; Bruce A. ; et al.	2016-04-21
Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics Grant 9,206,251 - Andrien, Jr. , et al. December 8, 2	2015-12-08
Anti-c5 Antibodies Having Improved Pharmacokinetics App 20150299305 - ANDRIEN, JR.; Bruce A. ; et al.	2015-10-22
Methods of treating C5 mediated complement-associated conditions with anti-C5 antibodies having improved pharmacokinetics Grant 9,107,861 - Andrien, Jr. , et al. August 18, 2	2015-08-18
Anti-C5 antibodies having improved pharmacokinetics Grant 9,079,949 - Andrien, Jr. , et al. July 14, 2	2015-07-14
Multipole ion guide ion trap mass spectrometry with MS/MS.sup.n analysis Grant 8,847,157 - Whitehouse , et al. September 30, 2	2014-09-30
Multipole Ion Guide Ion Trap Mass Spectrometry With Ms/msn Analysis App 20140124661 - Whitehouse; Craig M. ; et al.	2014-05-08
Direct flow injection analysis nebulization electrospray and APCI mass spectrometry Grant 7,364,913 - Andrien, Jr. , et al. April 29, 2	2008-04-29
Mass spectrometry with multipole ion guides Grant 7,189,967 - Whitehouse , et al. March 13, 2	2007-03-13
Mass spectrometry with multipole ion guides Grant 6,987,264 - Whitehouse , et al. January 17, 2	2006-01-17
Direct flow injection analysis nebulization electrospray and APCI mass spectrometry Grant 6,858,437 - Andrien, Jr. , et al. February 22, 2	2005-02-22
Mass spectrometry with multipole ion guides Grant 6,753,523 - Whitehouse , et al. June 22, 2	2004-06-22
Mass spectrometry from surfaces Grant 6,600,155 - Andrien, Jr. , et al. July 29, 2	2003-07-29
Atmospheric pressure ion sources Grant 6,593,568 - Whitehouse , et al. July 15, 2	2003-07-15
Multiple sample introduction mass spectrometry Grant 6,541,768 - Andrien, Jr. , et al. April 1, 2	2003-04-01
Disposable microtip probe for low flow electrospray Grant 6,337,480 - Andrien, Jr. , et al. January 8, 2	2002-01-08
Curved introduction for mass spectrometry Grant 6,326,616 - Andrien, Jr. , et al. December 4, 2	2001-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.